FMR LLC - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 24 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
FMR LLC ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q4 2020$2,126,000
+7.6%
2,257,0000.0%0.00%
Q3 2020$1,975,000
-9.2%
2,257,0000.0%0.00%
Q2 2020$2,174,000
+0.3%
2,257,0000.0%0.00%
Q1 2020$2,167,000
-7.3%
2,257,0000.0%0.00%
Q4 2019$2,338,000
-56.0%
2,257,000
-61.1%
0.00%
-100.0%
Q3 2019$5,311,000
+6.7%
5,807,0000.0%0.00%0.0%
Q2 2019$4,978,000
-10.6%
5,807,000
+1.0%
0.00%0.0%
Q1 2019$5,569,000
-5.8%
5,750,0000.0%0.00%0.0%
Q4 2018$5,915,000
-12.7%
5,750,0000.0%0.00%0.0%
Q3 2018$6,772,000
+18.8%
5,750,0000.0%0.00%0.0%
Q2 2018$5,700,000
-2.0%
5,750,0000.0%0.00%0.0%
Q1 2018$5,818,000
-14.7%
5,750,000
-8.0%
0.00%0.0%
Q4 2017$6,824,000
-10.8%
6,250,0000.0%0.00%0.0%
Q3 2017$7,652,000
-9.3%
6,250,0000.0%0.00%0.0%
Q2 2017$8,434,000
+7.0%
6,250,0000.0%0.00%0.0%
Q1 2017$7,883,000
-0.9%
6,250,000
-10.7%
0.00%0.0%
Q4 2016$7,958,0007,000,0000.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Context Capital Management, LLC 6,000,000$5,827,0003.55%
DeepCurrents Investment Group LLC 21,223,000$20,803,0001.80%
ZAZOVE ASSOCIATES LLC 19,230,000$18,725,0001.77%
Mohican Financial Management, LLC 500,000$494,0001.61%
Castle Creek Arbitrage, LLC 5,149,000$5,015,0001.47%
LINDEN ADVISORS LP 62,688,000$61,071,0001.40%
Verition Fund Management LLC 10,817,000$10,504,0000.41%
WOLVERINE ASSET MANAGEMENT LLC 24,100,000$23,451,0000.32%
Baupost Group 30,000,000$29,213,0000.24%
SSI INVESTMENT MANAGEMENT LLC 2,763,000$2,676,0000.22%
View complete list of THERAVANCE BIOPHARMA INC shareholders